Epi-LASIK治疗白内障摘出联合人工晶状体植入术后屈光不正的疗效观察

发布时间：2018-12-23 18:09

【摘要】：目的观察Epi-LASIK治疗白内障摘出联合人工晶状体(intraocular lens,IOL)植入术后屈光不正的临床疗效。方法选取白内障摘出联合IOL植入术后的屈光不正患者42例51眼实施Epi-LASIK,所有患者术前均接受详细的术前检查,术后随访6个月,观察患者恢复情况。结果术后6个月时,裸眼视力1.0者38眼(74.51%),≥0.8~1.0者9眼(17.65%),48眼(94.12%)达到术前最佳矫正视力。球镜度数(-0.39±0.47)D,其中±1.00 D以内者48眼(94.12%),±0.50 D以内者37眼(72.55%);柱镜度数(0.24±0.52)D,其中柱镜度数±1.00 D以内者为45眼(88.24%),±0.50 D以内者34眼(66.67%)。随访期内4眼(7.84%)出现0.5级haze,2眼(3.92%)1级haze,经治疗角膜均恢复透明;所有患者随访期内未见严重并发症发生。结论 Epi-LASIK治疗白内障摘出联合IOL植入术后屈光不正具有良好的安全性、有效性和可预测性。
[Abstract]:Objective to observe the effect of Epi-LASIK on refractive error after cataract extraction combined with intraocular lens (intraocular lens,IOL) implantation. Methods 42 patients (51 eyes) with ametropia after cataract extraction and IOL implantation underwent detailed preoperative examination before and after 6 months follow-up to observe the recovery of the patients. Results at 6 months after operation, the uncorrected visual acuity was 1.0 in 38 eyes (74.51%), 鈮，

本文编号：2390060